3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Carcinoma, Non-Small-Cell Lung
2
Thrombocytosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, Mantle-Cell
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Inhibition, Psychological
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
B-cell Malignancies
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
ruxolitinib
3
venetoclax
2
fludarabine phosphate
2
duvelisib
2
thymoglobulin
1
romidepsin
1
itacitinib
1
fludarabine
1
Whole-Body Irradiation
1
Stem Cell Transplantation
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Lisaftoclax
1
Depsipeptides
1
Cyclosporins
1
Cyclosporine
1
Cladribine
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Prolymphocytic, T-Cell
×
INCB039110
×
1 year
×
Clear all
No trials found.